Targeting antigens to CD205+ cells in the spleen using anti-CD205 antibodies has shown to be effective at deletion of autoreactive CD8+ T cells (110), and at inducing tolerance in several autoimmune disease models (111, 112). The gene discussed is LY75; the disease is autoimmune disease.